ClinicalTrials.gg
Sign In

Infant, Newborn, Diseases clinical trials

The registry lists 140 studies for Infant, Newborn, Diseases across more than 10 countries. 29 are recruiting or about to start. 61 of them are mainly about Infant, Newborn, Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 38 narrower conditions too, such as Cystic Fibrosis: 3,854 studies, 648 open.

Get an email when these change. Save the Infant, Newborn, Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
80
Recruiting
21
Status unknown
18
Active, not recruiting
9
Not yet recruiting
8
Terminated
3

Phase

Phase 3
19
Phase 2
18
Phase 1
10
Early Phase 1
1
Phase 4
1

Where

United States
43
United Kingdom
14
Canada
12
Germany
9
Turkey
9
France
8

Who runs them

National Center for Research Resources (NCRR) (12) · NICHD Neonatal Research Network (8) · Assiut University (5) · Vertex Pharmaceuticals Incorporated (5) · Kastle Therapeutics, LLC (4) · Ondokuz Mayıs University (3) · Medical University of Graz (3) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)

What is being tested here

Drugs under test in Infant, Newborn, Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Delpacibart zotadirsen111
Fluorodopa F 18101
Omeprazole101
Sodium Acetate111
Allopurinol111
Mipomersen024
Ivacaftor024
Morphine012
Hydrocortisone012
Thyrotropin-Releasing Hormone012

Drug classes tested here Corticosteroids 3

Coming up

5phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 21 Infant, Newborn, Diseases studies recruiting now, 3 (14%) set no upper age limit and 18 (86%) stop at 75 or younger. 17 (81%) take children under 18. 1 (5%) are for women only and 1 (5%) for men only; 5 (24%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
102 (10%)3 (14%)
185 (24%)4 (19%)
305 (24%)4 (19%)
405 (24%)4 (19%)
504 (19%)3 (14%)
654 (19%)3 (14%)
753 (14%)2 (10%)
853 (14%)2 (10%)

Across all 140 studies, recruiting or not: 77% stop at 75 or younger and 76% at 65; 89% take children; 6% are for women only and 1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Infant, Newborn, Diseases studies take

Of 32 observational studies under Infant, Newborn, Diseases, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase21 mo12–42 · 31 studies—19 mo12–37 · 30 studies
Observational25 mo15–39 · 32 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 140. Browse all 140 → or search them.